Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eucerin Plus is a topical moisturizing formulation typically containing emollients and humectants such as urea and alpha-hydroxy acids (e.g., lactic acid). It is designed to hydrate the stratum corneum and promote the exfoliation of dead skin cells, making it effective for treating dry, scaly skin conditions like xerosis and ichthyosis. In the specific clinical context of research conducted at Mount Sinai Hospital, Canada, Eucerin Plus was utilized as a placebo control in a randomized controlled trial (NCT00127582) evaluating the efficacy of topical amethocaine gel (Ametop) for reducing pain in neonates during intramuscular vitamin K injections. As a placebo, it lacks active anesthetic or analgesic properties and serves to maintain the blinding of the study by providing a similar tactile application to the experimental intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eucerin Plus.